Contactless optical monitoring of dialysis fistulas and grafts with the PatenSee system
Official title: A Prospective International Multicenter, Non-Interventional, Single Arm, Blinded Feasibility Study to Assess the Contactless Optical Monitoring of AV Access Using the PatenSee System in Dialysis Patients
Run by PatenSee Ltd. · NCT07194395 · Data updated 2026-11-12
This study will test a contactless camera-based system (PatenSee) to monitor arteriovenous fistulas or grafts in adults who receive regular hemodialysis.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 90 (estimated) |
| Sponsor | PatenSee Ltd. Industry-sponsored |
| Locations | 2 sites (Detroit, Michigan and 1 other locations) |
| Status | Recruiting |
| Started | June 6, 2025 |
| Main results expected | June 2026 |
| Study ends | February 28, 2027 |
| Registry record updated | September 26, 2025 |
| Trial ID | NCT07194395 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) with non-reversible kidney failure who are on long-term hemodialysis through a functioning upper-extremity AV fistula or graft and who can give informed consent and follow study procedures are ideal candidates.
✕Probably not a fit
Patients with an active AV access infection, those expected to have imminent access revision or to recover kidney function/receive a transplant or change dialysis modality, or those unable to comply with study visits are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, non-interventional, single-arm international multicenter study enrolling up to 120 adults on maintenance hemodialysis with a functioning upper-extremity AV fistula or graft. Participants will receive standard clinical AV access exams by qualified staff and will also have the PatenSee system capture optical data weekly for 6 weeks and then every two weeks for up to 1 year. PatenSee data will be analyzed and compared against standard-of-care clinical monitoring and imaging, while all clinical decisions remain based on routine care. Additional information on imaging results and access-related complications will be collected to correlate with the device output.
Why it matters
Potential benefit: If successful, the PatenSee system could provide a non-contact way to detect access problems earlier and complement routine exams, potentially reducing delays to intervention and clinic visits.
How similar studies have gone: Small pilot studies and research on camera- or optical-based monitoring of vascular access have shown promising early results, but large multicenter evaluations of commercial contactless systems remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Male and female adult patient aged ≥18 years old 2. Patient has a non-reversible kidney failure that requires long-term hemodialysis 3. Patient has a functioning AV access (AVF/G) in the upper extremity 4. Patient is able and willing to provide consent by signing an EC/IRB approved informed consent form 5. Patient is willing and able to follow the requirements of the study Exclusion Criteria: 1. An active AV access infection 2. An AV access condition that will likely require revision, e.g., symptomatic steal syndrome 3. Expected to recover kidney function, receive a kidney transplant, transfer to peritoneal dialysis (PD) or transfer to non-study site during the study period. 4. Any reason per investigator's discretion for which the patient is not suitable for the study 5. Any medical or psychiatric illness, which in the opinion of the investigator would compromise the patient's ability to adhere to study requirements 6. Previous participation in an interventional study within 30 days prior to study enrollment that may interfere with evaluation of the study endpoints 7. Female patient is pregnant or breastfeeding
Where it's running
-
Henry Ford Hospital
Detroit, Michigan, United States Recruiting -
Meir Medical Center
Kfar Saba, Hasharon, Israel Not yet recruiting
Study contacts
- Study coordinator: Naama Barel
- Email: Naama.b@patensee.com
- Phone: 972-508341678
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Video-based self-check for neonatal resuscitation skills in fourth-year midwifery students
This study tests whether watching and reflecting on videos of their own neonatal resuscitation practice helps fourth-year midwifery students improve skills, judgment, satisfaction, and confidence.
-
Bioimpedance Spectroscopy for Fluid Changes in Hemodialysis Patients
This study tests whether raw bioimpedance data can help doctors gauge fluid changes in people on hemodialysis and guides fluid removal decisions.
-
Nurse-led dialysis self-management program for distress in adults on hemodialysis
A nurse-led program helps adults on hemodialysis see if structured self-management support reduces dialysis-related distress compared to routine care.
-
Repeated brief limb ischemia to see its effect on blood pressure and inflammation in people with kidney disease
This study tests whether short, repeated episodes of limb ischemia can influence blood pressure, heart rate, and inflammation in adults with chronic kidney disease who may be on hemodialysis.
-
Mindfulness Meditation for Hemodialysis Patients
A small trial tests whether a 4-week mindfulness meditation program in addition to usual care can improve sleep quality and reduce stress and symptoms in adults on hemodialysis.
-
Progressive muscle relaxation to ease depression and fatigue during hemodialysis
This trial will try whether guided progressive muscle relaxation can reduce depression and fatigue in people receiving hemodialysis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.